Acquisition Fit VitaLink Research was acquired by Velocity Clinical Research, creating an expanded owner-site network with 30 integrated sites, signaling a stronger centralized operations model that can accelerate patient enrollment and improve study execution for potential CRO partnerships.

Expansion Footprint Velocity is actively expanding into Europe and building a broader global presence, which opens cross-border trial opportunities and the potential to serve multinational studies with standardized site operations and feasibility capabilities.

Feasibility Edge The recent launch of Feasibility Agent leveraging data from 70+ global sites suggests a competitive advantage in site selection and protocol feasibility, offering a strong upsell for sponsors seeking faster start-up and optimized site mix.

Analytics Capability Adoption of advanced analytics and tech stack including SageMaker and MicroStrategy indicates a data-driven approach to trial optimization, enabling value propositions around predictive enrollment, risk mitigation, and efficiency improvements.

Leadership & Partnerships Senior leadership movements and strategic partnerships, such as the Palantir collaboration and growth in executive team, point to a trajectory of enhanced reliability, governance, and potential co-sell opportunities with large sponsors and tech-enabled service offerings.